LISKA BIOMETRY SECURES 5MM IN FINANCING

June 9th,  Dover,  NH: Liska  Biometry Inc.,  provider of secure  identification
solutions,  completed a $5 million  financing  agreement  with a New  York-based
asset management firm.

The financing  consists of two separate  convertible  notes;  a $3 million note,
convertible in common stock at $0.40,  and a $2 million note,  convertible  into
common stock at $0.60. Both notes bear an interest rate of 10% per annum and are
due 2009 unless converted into common stock of Liska.  Liska also granted CAMOFI
warrants  exercisable  at any time prior to May 31,  2013,  to  purchase  12.5MM
shares of its Common Stock at an exercise price of $0.40 per share.  The company
will file a registration  statement with the Securities and Exchange  Commission
to register the common stock  issuable  upon  conversion of the notes as well as
the common stock underlying the warrants.

A portion of the proceeds of this  financing  were used to acquire Markow Photo.
The balance  will be used as working  capital to help fund the  company's  sales
growth, future acquisitions and intellectual property development.

"This  financing is an integral part of our success going  forward,  the capital
will  enable us to execute  our  mission of  becoming a global  player in secure
identification  solutions  ," said  Charles  Benz,  Chairman  and  CEO of  Liska
Biometry Inc. "Our industry is growing rapidly,  having Wall Street support will
enable us to execute on more opportunities in our space."


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

The Private  Securities  Litigation  Reform Act of 1995 (the "PSLRA") provides a
"safe harbor" for  forward-looking  statements so long as those  statements  are
identified as  forward-looking  and are  accompanied  by  meaningful  cautionary
statements  identifying  important  factors that could cause  actual  results to
differ materially from those projected in such statements.

Statements  contained  herein that are not based on historical fact , as well as
other  statements  including  words  such as  "anticipate,"  "believe,"  "plan,"
"estimate,"  "expect," "intend," "will," "could" and other similar  expressions,
constitute forward-looking statements under the PSLRA. Liska and DCS intend that
such  forward-looking  statements be subject to the safe harbor created thereby.
Such  forward-looking  statements are based on current  assumptions  but involve
known and unknown  risks and  uncertainties  that may cause Liska and DCS actual
results,   performance  or  achievements  to  differ   materially  from  current
expectations.   These  risks  include   economic,   competitive,   governmental,
technological and other factors  discussed in Liska annual,  quarterly and other
periodic  public filings on record with the  Securities and Exchange  Commission
which can be viewed free of charge on its website at http://www.sec.gov.


For more Liska information please contact:


Contact: Liska Biometry, Inc.

         Christopher J. LeClerc, President and CFO
         (603) 742-8100
         investors@liskabiometry.com
         www.liskabiometry.com